Cyclooxygenase-2 expression in lung cancer cells evaluated by immunocytochemistry
✍ Scribed by Andrea Koch; Bertil Gustafsson; Helena Fohlin; Sverre Sörenson
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 172 KB
- Volume
- 39
- Category
- Article
- ISSN
- 8755-1039
- DOI
- 10.1002/dc.21366
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Tobacco use is the most important risk factor for the development of lung carcinoma. One characteristic shared by tobacco‐related lung diseases is altered lung connective tissue content and composition. In particular, tobacco results in increased expression of fibronectin (FN), a matrix
## Abstract In addition to the known function in the glycolytic pathway, phosphoglycerate kinase 1 (PGK‐1) promotes reduction of plasmin disulfide bonds leading to angiostatin formation and inhibition of tumor angiogenesis. In this study, the effects of PGK‐1 on anti‐ tumor immunity against lung ca
Cyclooxygenase (COX)-2 is one of the rate-limiting enzymes in the conversion of arachidonic acid to prostaglandins and other eicosanoids. Recent studies have shown enhanced expression of COX-2 in cancer cells of several tissues. We investigated the expression of COX-2 and prostaglandin (PG) E 2 prod